Published: 23 February 2017

Will you help us develop future cancer treatments?

The University of Surrey is undertaking innovative research into cancer - but with your help we can do so much more.

Imagine it’s a sunny Sunday morning. You are sitting down with a coffee when you get a call that changes your world.

A loved one has been diagnosed with cancer.

Despite huge advances in the last decade in cancer detection and treatment, this insidious disease still blights the lives of millions of people. But the University of Surrey is undertaking pioneering research into cancer-causing viruses and our immune system, which could eventually lead to new immunotherapeutic ways of treating cancer and other debilitating diseases.

Our Faculty have received grants from major UK charities to fund their research. Professor David Blackbourn, Head of the Faculty of Health and Medical Sciences, is a recipient of significant funding from major cancer organisations who recognise the importance of his research in the fight against cancer.

Professor Blackbourn said: “Through the development of these innovative treatments we hope to improve quality of life for patients.”

Surrey is also carrying out ground-breaking research into diagnosing prostate cancer.

One of the biggest challenges in beating prostate cancer is accurate detection. The standard detection method is the 30 year-old PSA test. But 76% of men who show raised levels of PSA do not have the disease, leading to unnecessary and invasive testing.

The University of Surrey has developed a new way of more reliably detecting prostate cancer with a urine sample. Early evidence has indicated this test is twice as effective as PSA and costs half the amount.

Dr Colin Stokes, MBE, chair of partner group the Prostate Project, said: “There is no doubt that it will save many lives and I would thank our many generous supporters who have helped make it possible.”

By making a gift today you can help our researchers like David and Hardev continue their research:


Read more about cancer research at the University of Surrey.

Share what you've read?